NAFLD and NASH were defined by the ultrasound finding with an elevated alanine transaminase (27-53.9 and ≥54 U/L in men and 15-29.9 and ≥30 U/L in women, respectively). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatohepatitis.